✦ LIBER ✦

Do Anti-CD25 Monoclonal Antibodies Potentiate Posttransplant Diabetes Mellitus?

✍ Scribed by B. Bayés; M.C. Pastor; R. Lauzurica; M.L. Granada; I. Salinas; R. Romero

Book ID: 116933540
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 61 KB
Volume: 39
Category: Article
ISSN: 0041-1345
DOI: 10.1016/j.transproceed.2007.06.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of posttransplantation diabete

Treatment of posttransplantation diabetes mellitus with anti-CD20 monoclonal antibodies

✍ K. Vandenbosch; M.A. Champagne; M. Gonthier; A. Moghrabi; M.-F. Vachon; M. Duval 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Anti-CD3 Monoclonal Antibody in New-Onse

Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes Mellitus

✍ Herold, Kevan C.; Hagopian, William; Auger, Julie A.; Poumian-Ruiz, Ena; Taylor, 📂 Article 📅 2002 🏛 Massachusetts Medical Society 🌐 English ⚖ 110 KB

Otelixizumab – dose regimen optimization

Otelixizumab – dose regimen optimization of a chimeric/humanized aglycosylated anti-CD3 monoclonal antibody (MAb) in adult subjects with type 1 diabetes mellitus (T1DM)

✍ Rosenzweig, M.; Mehta, D.; Forman, D.; McKee, C.; Vaickus, L. 📂 Article 📅 2009 🏛 Canadian Diabetes Association 🌐 English ⚖ 436 KB